The Academy is working across the research community and Government to understand and respond to the impacts of leaving the EU on UK medical sciences.Ongoing
Research and the European Union
On the 23 June 2016, the UK voted to leave the European Union. This represents one of the most profound challenges to the medical research sector in living memory, and the Academy is now working with the UK Government, devolved administrations and the wider research community to identify and undertake the bold actions needed to preserve the UK’s world-leading research environment.
The Academy is engaged with many ongoing activities:
- Submitting evidence to the Commons Exiting the EU Select Committee inquiry into 'UK's negotiating objectives for withdrawal from EU inquiry' in January 2017.
- Jointly submitting evidence to the Commons Home Affairs Committee inquiry into 'Immigration' in January 2017.
- Hosting events at the 2016 Party Conferences titled 'Open for business: a nation of global researchers, innovators and industrialists'.
- Providing input to the UK-EU Life Sciences Transition Programme report, which explores the Brexit transition for the life sciences sector.
- Submitting evidence to the Commons Science & Technology Committee inquiry into 'Leaving the EU' and the Scottish Parliament inquiry into the EU referendum, in August 2016.
- Publishing a joint statement with national Academies from across Europe in July 2016, on the international nature of research. This was accompanied by the #ScienceIsGlobal social media campaign.
- Publishing a joint statement with seven Academies from across the UK, in July 2016, listing key priorities for research, including the need for urgent action around funding and the rights of EU researchers in the UK.
- The President explored key issues relating to Brexit in his address to New Fellows of the Academy in July 2016.
- Issuing a reaction from the President in June 2016, reflecting on the need to safeguard the global reputation of UK science.
Prior to the referendum, the Academy sought to inform debate around the benefits and challenges of EU membership for UK research, by:
- Providing written and oral evidence to the House of Lords Science & Technology Committee inquiry into the impact of EU membership on research.
- Submitting written evidence to the House of Commons Science & Technology Committee inquiry which focused on the impact of EU regulations on UK life sciences.
- Issuing a statement highlighting the mobility, collaborative, funding and regulatory implications for research associated with a possible departure from the EU.